Mammalian interleukin-10 (IL-10) super-activating receptors; and variants
    5.
    发明授权
    Mammalian interleukin-10 (IL-10) super-activating receptors; and variants 失效
    哺乳动物白细胞介素-10(IL-10)超激活受体; 和变体

    公开(公告)号:US5716804A

    公开(公告)日:1998-02-10

    申请号:US424788

    申请日:1995-04-19

    CPC分类号: C07K14/7155 A61K38/00

    摘要: Amino acid sequence and nucleic acid encoding various functional variants of the IL-10 receptors. Uses of the receptor gene and polypeptides are disclosed, including means for screening for agonists and antagonists of the receptor ligands, for producing diagnostic or therapeutic reagents, and for producing antibodies. Therapeutic or diagnostic reagents and kits are also provided.

    摘要翻译: 氨基酸序列和编码IL-10受体的各种功能变体的核酸。 公开了受体基因和多肽的用途,包括用于筛选受体配体的激动剂和拮抗剂,用于产生诊断或治疗试剂以及产生抗体的手段。 还提供治疗或诊断试剂和试剂盒。

    Interleukin—1 receptor antagonist and uses thereof
    6.
    发明授权
    Interleukin—1 receptor antagonist and uses thereof 失效
    白细胞介素-1受体拮抗剂及其用途

    公开(公告)号:US06541623B1

    公开(公告)日:2003-04-01

    申请号:US09576008

    申请日:2000-05-22

    IPC分类号: C07H2104

    摘要: The present invention provides novel nucleic acids, the novel polypeptide sequences encoded by these nucleic acids and uses thereof. These novel polynucleotide and polypeptide sequences were determined to be a novel Interleukin-1 Receptor Antagonist.

    摘要翻译: 本发明提供了新的核酸,由这些核酸编码的新的多肽序列及其用途。 这些新的多核苷酸和多肽序列被确定为新的白细胞介素-1受体拮抗剂。

    Therapeutic uses of il-1 receptor antagonist
    7.
    发明授权
    Therapeutic uses of il-1 receptor antagonist 失效
    il-1受体拮抗剂的治疗用途

    公开(公告)号:US06497870B1

    公开(公告)日:2002-12-24

    申请号:US09576755

    申请日:2000-05-22

    IPC分类号: A61K4500

    CPC分类号: C07K14/54 A61K38/00 Y02A50/41

    摘要: The present invention provides novel therapeutic methods of administering an amount of IL-1Ra to treat IL-18 related disorders. Specifically, the method involves treating IL-18 related disorders such as liver injury, hepatis, hemophagocytic lymphohistiocytosis, multiple sclerosis, tumors, cytotoxicity resulting from antitumor therapy, or other autoimmune disorders with a therapeutically effective amount of IL-1ra, and optionally measuring IFN-&ggr; and IL-18 activity from human samples.

    摘要翻译: 本发明提供了施用一定量的IL-1Ra以治疗IL-18相关病症的新型治疗方法。 具体地说,该方法包括治疗IL-18相关疾病如肝损伤,肝细胞,嗜血细胞淋巴组织细胞增多症,多发性硬化,肿瘤,抗肿瘤治疗引起的细胞毒性或其它具有治疗有效量的IL-1ra的自身免疫性疾病,以及任选地测量IFN -γ和IL-18活性。